Chimeric antigen receptor T (CAR-T) cells expanded with IL-7/IL-15 mediate superior antitumor effects

被引：90
|
作者：
Zhou, Jianxia [1 ,2 ]
Jin, Liyuan [1 ,2 ]
Wang, Fuping [1 ,4 ]
Zhang, Yuan [1 ,2 ]
Liu, Bing [3 ]
Zhao, Tongbiao [1 ,2 ]
机构：
[1] Chinese Acad Sci, State Key Lab Reprod Biol, Inst Zool, Beijing 100101, Peoples R China
[2] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China
[3] Acad Mil Med Sci, State Key Lab Prote, Translat Med Ctr Stem Cells, Ivy Translat Med Ctr 307,Lab Oncol,Affiliated Hos, Beijing 100071, Peoples R China
[4] Hebei Univ, Coll Life Sci, Baoding 071002, Peoples R China
来源：
PROTEIN & CELL | 2019年 / 10卷 / 10期
基金：
国家重点研发计划; 中国国家自然科学基金;
关键词：
IMMUNOGLOBULIN; THERAPY; IL-7;
D O I：
10.1007/s13238-019-0643-y
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：764 / 769
页数：6
相关论文
共 50 条
  • [1] Chimeric antigen receptor T(CAR-T) cells expanded with IL-7/IL-15 mediate superior antitumor effects
    Jianxia Zhou
    Liyuan Jin
    Fuping Wang
    Yuan Zhang
    Bing Liu
    Tongbiao Zhao
    Protein & Cell, 2019, 10 (10) : 764 - 781
  • [2] γc Cytokines IL7 and IL15 Expanded Chimeric Antigen Receptor-Redirected T Cells (CAR-T) with Superior Antitumor Activity In Vivo
    Xu, Yang
    Zhang, Ming
    Mahendravada, Aruna
    Savoldo, Barbara
    Dotti, Gianpietro
    MOLECULAR THERAPY, 2013, 21 : S20 - S21
  • [3] Shortened T Cell Culture with IL-7 and IL-15 Provides the Most Potent Chimeric Antigen Receptor (CAR)-Modified T Cells for Adoptive Immunotherapy
    Ghassemi, Saba
    Bedoya, Felipe
    Nunez-Cruz, Selene
    June, Carl
    Melenhorst, Jos
    Milone, Michael
    MOLECULAR THERAPY, 2016, 24 : S79 - S79
  • [4] IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation
    Battram, Anthony M.
    Bachiller, Mireia
    Lopez, Victor
    Fernandez de Larrea, Carlos
    Urbano-Ispizua, Alvaro
    Martin-Antonio, Beatriz
    CANCERS, 2021, 13 (14)
  • [5] BCMA-TARGETING CAR-T CELLS EXPANDED IN IL-15 HAVE AN IMPROVED PHENOTYPE FOR THERAPEUTIC USE COMPARED TO THOSE GROWN IN IL-2 OR IL-15/IL-7
    Battram, Anthony
    Bachiller, Mireia
    Urbano-Ispizua, Alvaro
    Martin-Antonio, Beatriz
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A65 - A65
  • [6] Bispecific LV20.19 CAR T-Cells Expanded in IL-7 and IL-15 Have Greater Polyfunctionality and Polyfunctional Strength Than CAR T-Cells Expanded in IL-2
    Zurko, Joanna C.
    Xu, Huiqing
    Chaney, Katherine
    Fenske, Timothy S.
    Hamadani, Mehdi
    Schneider, Dina
    Hari, Parameswaran
    Johnson, Bryon
    Shah, Nirav N.
    BLOOD, 2021, 138
  • [7] Maintenance of memory CD8 T cells by intrinsic levels of the IL-7 receptor and the IL-15 receptor
    Shen, Ching-Hung
    Talay, Oezcan
    Ge, Qing
    Harriman, Jim
    Chen, Jianzhu
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S305 - S305
  • [8] The influence of IL-2, IL-7, and IL-15 on human T cells for cancer therapy
    Dovedi, Simon
    Gilham, David
    Hawkins, Robert E.
    HUMAN GENE THERAPY, 2007, 18 (10) : 1063 - 1063
  • [9] Chimeric Antigen Receptor beyond CAR-T Cells
    Qin, Vicky Mengfei
    D'Souza, Criselle
    Neeson, Paul J.
    Zhu, Joe Jiang
    CANCERS, 2021, 13 (03) : 1 - 16
  • [10] Effect of IL-7 and IL-15 on T cell phenotype in myelodysplastic syndromes
    Dong, Wen
    Ding, Tingting
    Wu, Lei
    Ren, Xiubao
    Epling-Burnette, P. K.
    Yang, Lili
    ONCOTARGET, 2016, 7 (19) : 27479 - 27488
12345